Levocetirizine dihydrochloride
盐酸左西替利嗪
Report date: 2026/05/24 20:00:34
NME
Base Information
Drug NameLevocetirizine dihydrochloride
Drug Alias Name +[13]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[16]
Global Approved Indications +[10]
Approved Indications in China +[4]
Original Approved Country/Territory
Original Approved Date2001/01/03
Country/Territory +[16]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUcb
China Registration ClassN/A
Develop Information
Active CompaniesMubadala Investment CompanyCBC Co LtdEunice Kennedy Shriver National Institute Of Child Health And Human Development +[6]
Inactive CompaniesUcb PharmaClinical Research International LtdDr.Reddy's Laboratories Ltd
Active Indications +[12]
Inactive Indications +[4]